Tekmira +4% on takeover rumors; Shire, Glaxo said to have interest

|By:, SA News Editor

Tekmira Pharma (NASDAQ:TKMR) +4.2% AH following a Daily Mail story suggesting it is a takeover candidate, after shares have nearly doubled in the past month thanks to attention over its experimental treatment for the deadly ebola virus.

Rumors suggest interested parties could include Shire (NASDAQ:SHPG) and GlaxoSmithKline (NYSE:GSK); the report suggests the recent premium paid for  InterMune could put a valuation of at least $40/share on TKMR.